
- Pharmaceutical Technology-09-02-2013
- Volume 37
- Issue 9
XstalBio Introduces CentuRecon
CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration.
CentuRecon, a patented reconstitution technology, decreases the preparation time of high concentration protein solutions from dry powder formulations and makes delivery faster and safer, according to the company. CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration and produces foam-free solutions that maximize the deliverable dose. CentuRecon is compatible with standard lyophilized formulations and diluents and with normal vials, cartridges, or dual-chamber syringes. It can be used for very high concentration and/or viscous solutions that may need to be delivered with injection devices.
Articles in this issue
over 12 years ago
The Importance of Continued Investment in R&Dover 12 years ago
FDA Works to Secure Drug Supply Chainover 12 years ago
Outsourcing Partnerships for CMC Developmentover 12 years ago
MF40 Automated Punch and Die Polishing Machineover 12 years ago
Quality by Design in APIsover 12 years ago
Connecting People, Science, and Regulationover 12 years ago
Effective and Efficient Weighing of Potent Compoundsover 12 years ago
EU Raises API Standards: A Curse in Disguise?over 12 years ago
The Importance of Characterization in Biosimilars Developmentover 12 years ago
Omega Design Corporation Introduces LabelSync 450Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





